Page last updated: 2024-10-24

chlorambucil and Urinary Retention

chlorambucil has been researched along with Urinary Retention in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Urinary Retention: Inability to empty the URINARY BLADDER with voiding (URINATION).

Research Excerpts

ExcerptRelevanceReference
"We report a case of Lymphocytic Lymphoma presenting with primary manifestation in the prostate."1.42[Primary manifestation of small Lymphocytic Lymphoma in the Prostate: A case report]. ( Bellaaj, H; Boudawara, T; Elloumi, M; Gouiaa, N; Kassar, O; Mdhaffar, M; Mhiri, N; Mseddi, S, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kassar, O1
Gouiaa, N1
Mdhaffar, M1
Bellaaj, H1
Mseddi, S1
Boudawara, T1
Mhiri, N1
Elloumi, M1

Other Studies

1 other study available for chlorambucil and Urinary Retention

ArticleYear
[Primary manifestation of small Lymphocytic Lymphoma in the Prostate: A case report].
    La Tunisie medicale, 2015, Volume: 93, Issue:4

    Topics: Aged, 80 and over; Antineoplastic Agents, Alkylating; Chlorambucil; Humans; Leukemia, Lymphocytic, C

2015